Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for healthcare industry professionals · Saturday, May 31, 2025 · 817,912,850 Articles · 3+ Million Readers

Global Sports Medicine Market Set to Reach $11.3B by 2031, Driven by Innovation | DataM Intelligence

Sports Medicine Market

Sports Medicine Market

Global sports medicine market to hit $11.3B by 2031, driven by innovation, aging athletes, and rising injuries. Explore trends, regions, and key players.

By 2031, the sports medicine market will hit $11.3B driven by tech, aging athletes, and a 6.3% CAGR redefining injury recovery, performance, and preventive care worldwide.”
— DataM Intelligence

AUSTIN, TX, UNITED STATES, May 30, 2025 /EINPresswire.com/ -- The global sports medicine market reached US$ 7.0 billion in 2022 and is projected to witness lucrative growth, reaching approximately US$ 11.3 billion by 2031. Over the forecast period from 2024 to 2031, the market is expected to register a compound annual growth rate (CAGR) of 6.3%.

The sports medicine market is on a strong growth trajectory, propelled by rising global participation in sports, greater awareness of physical fitness, and continuous innovation in injury treatment and rehabilitation. This report offers a comprehensive view of the market’s current size, future growth potential, regional insights, major players, and notable developments particularly in the United States and Japan.

Download Exclusive Sample Report Here: https://datamintelligence.com/download-sample/sports-medicine-market

This expansion is fueled by a mix of factors such as:

The increasing rate of sports-related injuries.

Growing demand for minimally invasive surgical procedures.

Technological innovations in wearable and regenerative medicine.

A rising aging population engaged in fitness routines to maintain mobility and health.

Regional Outlook

North America
North America remains the leader in the sports medicine space. In 2024, the region accounted for nearly half of the global market revenue. The U.S., in particular, stands out due to its strong sports culture, highly developed healthcare infrastructure, and investments in R&D. The U.S. market alone is expected to grow from around USD 2.36 billion in 2024 to more than USD 5.29 billion by 2034, indicating strong demand and innovation across orthopaedic care, joint repair, and performance monitoring technologies.

Asia-Pacific
The Asia-Pacific region is expected to experience the most rapid growth in the coming decade. Countries like China, Japan, South Korea, and India are increasingly adopting advanced medical technologies and investing heavily in sports medicine training, research, and infrastructure. Growing health consciousness, expanding middle-class populations, and national sports initiatives are boosting the region’s appeal. By 2033, Asia-Pacific's market value is expected to double, reaching around USD 3.44 billion.

Key Players in the Market

Arthrex Inc

CONMED Corporation

Johnson & Johnson

Medtronic PLC

Mueller Sports Medicine Inc

Performance Health

Smith & Nephew

Stryker Corporation

Wright Medical Group

Zimmer Biomet Holdings Inc

Innovations and Trends

The sports medicine industry is witnessing transformative changes thanks to rapid technological evolution. Some notable trends include:
Wearable Technology: Real-time monitoring of muscle strain, heart rate, hydration, and recovery is becoming standard for both professional and amateur athletes.

Regenerative Medicine: Stem cell therapy, platelet-rich plasma (PRP), and tissue engineering are opening new doors in sports injury recovery.

AI and Data Analytics: Algorithms are being used to customize training regimens, monitor rehabilitation progress, and prevent injuries before they occur.

Together, these innovations are shifting the focus of sports medicine from reactive care to proactive and preventive healthcare.

Latest News

Latest News in the USA
The United States continues to lead the sports medicine industry with major corporate and clinical advancements:
Smith & Nephew’s Robust Q1 Performance: The company reported a 3.2% year-over-year increase in orthopaedic sales, driven by improved performance in U.S. hip and knee implants, underscoring a rebound in elective procedures.

J&J MedTech’s Distribution Deal: In November 2024, Johnson & Johnson MedTech entered into a U.S.-exclusive distribution partnership with Responsive Arthroscopy Inc. This strategic move is set to strengthen its minimally invasive soft tissue repair offerings, especially for ACL and rotator cuff repairs.

Sword Health's Expansion: This digital physical therapy platform continues to scale operations in the U.S., using AI-powered therapy programs for personalized recovery and injury prevention. Sword Health’s solutions are being adopted not only by athletes but also by corporate wellness programs.

Latest News in Japan

Japan is emerging as a hotspot for sports medicine innovation, partly driven by its preparation for global sporting events:
Tokyo to Host 2025 World Athletics Championships: Scheduled for September 13–21, 2025, this event is expected to elevate the demand for sports injury management and athletic rehabilitation services.

Summer Deaflympics 2025: Japan will host this prestigious event from November 15–26, 2025. With a focus on inclusivity, this will spotlight sports medicine solutions designed for athletes with disabilities, setting a precedent for accessible healthcare.

Bain Capital Acquires Tanabe Pharma: In a USD 3.3 billion deal, Bain Capital took over Tanabe Pharma from Mitsubishi Chemical Group. The acquisition is likely to result in faster drug development cycles, including potential breakthroughs in regenerative therapies used in sports medicine.

Market Segmentation:

By Product: Body Support and Recovery, Body Reconstruction and Repair, Body Monitoring and Evaluation Devices, Accessories.

By Application: Back & Spine Injuries, Ankle & Foot Injuries, Elbow & Wrist Injuries, Hip Injuries, Others.

By End User: Hospitals, Specialty Clinics, Others.

By Region: North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.


Conclusion

The global sports medicine market is steadily evolving from a traditional injury treatment segment into a dynamic, high-tech ecosystem. With a solid CAGR of 6.3% expected from 2024 to 2031 and a projected market size of over USD 11.3 billion by the end of that period, the sector holds promising opportunities. The market is being reshaped by smart technologies, regenerative therapies, and growing health consciousness.

Whether in the advanced ecosystems of the U.S. or the rapidly modernizing healthcare framework of Japan, sports medicine is increasingly seen not just as a treatment avenue but as a vital component of holistic health and athletic performance. Stakeholders from healthcare providers to investors—should closely monitor these trends to seize future growth opportunities.

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Related Reports:

Powered Prosthetics Market

Foot and Ankle Devices Market

Sai Kumar
DataM Intelligence 4market Research LLP
+1 877-441-4866
email us here
Visit us on social media:
LinkedIn
X

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release